CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 121 filers reported holding CARA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $99,000 | -54.8% | 10,598 | -56.0% | 0.00% | -50.0% |
| Q2 2022 | $219,000 | +51.0% | 24,086 | +100.7% | 0.00% | +100.0% |
| Q1 2022 | $145,000 | -3.3% | 11,999 | -2.6% | 0.00% | 0.0% |
| Q4 2021 | $150,000 | -89.9% | 12,324 | -88.7% | 0.00% | -75.0% |
| Q3 2017 | $1,491,000 | – | 108,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,702,110 | $439,144 | 0.04% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,935,718 | $499,415 | 0.01% |
| ADAR1 Capital Management, LLC | 159,469 | $41,143 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 414,731 | $107,001 | 0.01% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,556,251 | $401,513 | 0.00% |
| Virtu Financial LLC | 75,987 | $20 | 0.00% |
| Corsair Capital Management | 19,864 | $5,125 | 0.00% |
| WEALTH EFFECTS LLC | 13,500 | $3,483 | 0.00% |
| Cypress Capital Management LLC (WY) | 5,000 | $1,290 | 0.00% |
| Citadel Advisors | 5,000 | $1,290 | 0.00% |